Prospectus Supplement No. 1

(To Prospectus Dated July 31, 2017)

 

Filed Pursuant to Rule 424(b)(3)

Registration No. 333-214073

 

IOVANCE BIOTHERAPEUTICS, INC.

 

Common Stock

 

This Prospectus Supplement supplements, and should be read in conjunction with, our Prospectus included in Post-Effective Amendment No. 1 to Registration Statement on Form S-3 (Registration No. 333-214073) dated July 31, 2017 (the “ Prospectus ”). This Prospectus Supplement must be delivered with the Prospectus.

 

The information in the Prospectus in the section titled “Selling Stockholders” is amended by this Prospectus Supplement to reflect changes in our registered securities by Ashish Jhingan, Dolly Jhingan, Ashish Jhingan & Dolly Jhingan JT WROS, Prasad Family Trust UAD 08/18/11, Subir Prasad, Trustee, and Joseph Telushkin.

 

Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or passed upon the adequacy or accuracy of this Prospectus Supplement. Any representation to the contrary is a criminal offense.

 

The date of this Prospectus Supplement is October 26, 2017.

 

 

     

 

 

SELLING STOCKHOLDERS

 

SUPPLEMENTAL INFORMATION

 

The table beginning on page 7 of the Prospectus in the section titled “Selling Stockholders” is amended as follows.

 

The table is hereby revised to reflect the following transfers: (i) Ashish Jhingan, Dolly Jhingan, and Ashish Jhingan & Dolly Jhingan JT WROS transferred warrants to purchase 37,500 shares of our common stock to OTA LLC. (ii) Joseph Telushkin transferred 3,185 shares of common stock to Shira Telushkin, Benjamin Telushkin, Naomi Telushkin, and Congregation Ramath Orah. In addition, the table is revised to adjust and correct the number of shares owned by Prasad Family Trust UAD 08/18/11, Subir Prasad, Trustee. OTA LLC, Shira Telushkin, Benjamin Telushkin, Naomi Telushkin, Congregation Ramath Orah, Joseph Telushkin, and Prasad Family Trust UAD 08/18/11, Subir Prasad, Trustee shall henceforth be treated as a selling stockholder for purposes of the Prospectus. The beneficial ownership information for the selling stockholder listed below is as of October 26, 2017.

 

 

 

Beneficial Ownership

Before Offering

 

 

Beneficial Ownership

After Offering

 

 

Selling Stockholder  

 

Number of

  Shares  

 

 

  Percent  

Number of Shares

  Being Offered  

 

Number of

  Shares  

 

 

  Percent  

OTA LLC          37,500(4) * 37,500 0 -
           
Shira Telushkin 800(2) * 800 0 -
           
Benjamin Telushkin 1,000(2) * 1,000 0 -
           
Naomi Telushkin 500(2) * 500 0 -
           
Congregation Ramath Orah 885(2) * 885 0 -
           
Joseph Telushkin 500(2) * 500 0 -
           
Prasad Family Trust UAD 08/18/11, Subir Prasad, Trustee 20,000(2) * 20,000 0 -

 

 

* Less than 1%

 

(2) Consists solely of currently outstanding shares of common stock.
(4) Consists solely of shares of common stock issuable upon exercise of a November 2013 Warrant.

 

 

  2  

Iovance Biotherapeutics (NASDAQ:IOVA)
Historical Stock Chart
From Feb 2024 to Mar 2024 Click Here for more Iovance Biotherapeutics Charts.
Iovance Biotherapeutics (NASDAQ:IOVA)
Historical Stock Chart
From Mar 2023 to Mar 2024 Click Here for more Iovance Biotherapeutics Charts.